Key result
ACE/ACE2 imbalance may explain severe COVID-19 cases in patients with comorbidities.
Why the study?
The role of ACE/ACE2 imbalance in various organs and its relation to comorbidities leading to severe COVID-19 cases is not fully understood.
The imbalance of ACE/ACE2 may play a crucial role in the pathophysiology of severe COVID-19, particularly in elderly patients and those with pre-existing comorbidities.
Answers are grounded in this paper and cite their sources.
ACE/ACE2 imbalance may refine comorbidity risk stratification in COVID-19; leaves open whether targeted modulation improves outcomes.
The outbreak of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a global catastrophe. The elderly and people with comorbidity are facing a serious complication of the disease. The entry and infection strategy of SARS-CoV-2 in a host cell is raised by an amazing way of angiotensin-converting enzyme (ACE) 2 (ACE2) receptor recognition and imbalance of ACE/ACE2 in various organs, especially in the lungs. Here it has been discussed the role of interferon and protease during the receptor recognition (begining of infection) and followed by the impact of cytokine and hypoxia in the context of the balance of ACE/ACE2. It has also very concisely delineated the biochemistry and mechanism of ACE/ACE2 balance in different stages of infection and its role in comorbidity.
No takes yet. Share an insight, caveat, or question.
Bank et al. (2021) conducted a review in COVID-19. ACE/ACE2 balance was evaluated. The balance of ACE/ACE2, influenced by interferons, proteases, cytokines, and hypoxia, plays a crucial role in SARS-CoV-2 infection and may explain severe COVID-19 cases in patients with comorbidities.
Synapse has enriched 10 related papers. Consider them for comparative context: